Santiago - Delayed Quote USD

Merck & Co., Inc. (MRK.SN)

78.71
+2.05
+(2.67%)
At close: April 25 at 10:09:20 AM GMT-4

Research Analysis

Revenue vs. Earnings

Revenue 15.53B
Earnings 5.61B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
15B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 14132524
Avg. Estimate 15.86B17.14B65.03B68.62B
Low Estimate 15.52B16.81B64.19B66.31B
High Estimate 16.23B17.44B66.43B72.33B
Year Ago Sales 16.11B16.66B64.17B65.03B
Sales Growth (year/est) -1.56%2.90%1.35%5.52%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
MRK.SN --------
S&P 500 13.32%2.61%7.73%13.77%

Upgrades & Downgrades

Downgrade Citigroup: Buy to Neutral 5/14/2025
Initiated Cantor Fitzgerald: Neutral 4/22/2025
Reiterates Guggenheim: Buy to Buy 4/17/2025
Downgrade Deutsche Bank: Buy to Hold 2/18/2025
Maintains Guggenheim: Buy to Buy 2/12/2025
Maintains B of A Securities: Buy to Buy 2/5/2025

Related Tickers